MediWound Inventory 2012-2024 | MDWD

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

MediWound inventory from 2012 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

MediWound inventory from 2012 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.

Related Stocks
Company Name	Market Cap
Zoetis (ZTS)	$87.5B
Takeda Pharmaceutical (TAK)	$47.5B
Merck (MKGAF)	$24.4B
Astellas Pharma (ALPMY)	$22B
Sandoz Group AG (SDZNY)	$17.6B
Summit Therapeutics (SMMT)	$16.8B
United Therapeutics (UTHR)	$15.6B
Shionogi (SGIOY)	$13.3B
Neurocrine Biosciences (NBIX)	$12.2B
Catalent (CTLT)	$10.9B
Revolution Medicines (RVMD)	$7.7B
Orion OYJ (ORINY)	$7.4B
Jazz Pharmaceuticals (JAZZ)	$6.9B
Ionis Pharmaceuticals (IONS)	$6.2B
Hikma Pharmaceuticals Plc (HKMPF)	$5.7B
Madrigal Pharmaceuticals (MDGL)	$5.3B
Crinetics Pharmaceuticals (CRNX)	$4.3B
Corcept Therapeutics (CORT)	$4.3B
Dyne Therapeutics (DYN)	$3.7B
PTC Therapeutics (PTCT)	$2.8B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.7B
Arrowhead Pharmaceuticals (ARWR)	$2.6B
Catalyst Pharmaceuticals (CPRX)	$2.5B
Soleno Therapeutics (SLNO)	$2B
Recursion Pharmaceuticals (RXRX)	$2B
Centessa Pharmaceuticals (CNTA)	$1.8B
BioCryst Pharmaceuticals (BCRX)	$1.7B
Xencor (XNCR)	$1.7B
Harrow (HROW)	$1.6B
Cassava Sciences (SAVA)	$1.5B